Extracorporeal Membrane Oxygenation Cannula Market To Reach $43.82 Million By 2030

Extracorporeal Membrane Oxygenation Cannula Market Growth & Trends

The global extracorporeal membrane oxygenation cannula market size is anticipated to reach USD 43.82 million by 2030, registering a CAGR of 4.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of respiratory & cardiac disorders is the major factor contributing to market growth. For instance, in November 2023, the National Health Commission in China noted a rise in respiratory illnesses, attributing it to the relaxation of COVID-19 measures and the presence of familiar pathogens like influenza, mycoplasma pneumonia, respiratory syncytial virus (RSV), and SARS-CoV-2. The global healthcare landscape is significantly influenced by the expanding elderly population, leading to a surge in age-related ailments, such as heart and lung diseases.

The World Health Organization (WHO) predicted that by 2030, one in every six people worldwide will be aged 60 years or older, with the population in this age group projected to increase from 1 billion in 2020 to 1.4 billion. Conditions, such as congestive heart failure, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, frequently culminate in respiratory or cardiac failure, often necessitating advanced life support interventions like ECMO therapy. As such, the prevalence of these conditions underscores the importance of enhancing healthcare infrastructure and services to cater to the evolving needs of aging populations globally. Moreover, ECMO is utilized in instances of cardiac or respiratory failure when conventional interventions like Cardiopulmonary Resuscitation (CPR) have not yielded success.

Its utilization spans a spectrum of medical scenarios, encompassing Extracorporeal CO2 Removal (ECCO2R), pediatric and neonatal care, acting as a conduit to recovery or transplantation, facilitating in-hospital transport, managing cardiac arrest, and addressing both cardiac and respiratory failure. Furthermore, there has been a growing acceptance of ECMO for in-hospital transport within critical care environments. As per an article published by the National Institute of Health (NIH) in August 2023, adults suffering from obesity may findextracorporeal membrane oxygenation (ECMO), an advanced form of respiratory support, beneficial during intensive care for respiratory failure. Hence, the growing applications of ECMO are expected to contribute to market growth.

 Request a free sample copy or view report summary: Extracorporeal Membrane Oxygenation Cannula Market Report

Extracorporeal Membrane Oxygenation Cannula Market Report Highlights

• The veno-arterial type segment held the largest share of around 45% in 2023 and is expected to grow at the fastest CAGR of 5.0% from 2024 to 2030 owing to the wide use of Veno-Arterial (VA) ECMO systems & circuits for circulatory and respiratory functions

• The adult patient type segment held the largest share of around 64% in 2023 and is anticipated to witness the fastest growth from 2024 to 2030 due to many patients suffering from respiratory conditions, such as ARDS

• The respiratory application segment accounted for the largest share of around 47% in 2023 due to the extensive use of ECMO in various respiratory conditions, such as respiratory distress syndrome, respiratory failure, pneumonia, and pulmonary hypertension In addition, the high prevalence of these conditions will propel the segment growth further

• The Extracorporeal Cardiopulmonary Resuscitation (ECPR) segment will witness the fastest CAGR of 5.25% from 2024 to 2030 due to the rising use of E?CPR for treating patients with cardiac arrest who do not respond to conventional cardiopulmonary resuscitation

• The hospitals end-use segment dominated with a 54.69% share in 2023 as they are preferred for treatments and surgeries due to the availability of various services under one roof

• The ambulatory surgical centers segment is expected to grow at the fastest CAGR from 2024 to 2030

• In February 2021, Medtronic temporarily modified its critical care products to address COVID-19 as per the guidelines of the FDA. Products such as Bio-Medicus Adult Cannula and Introducers, Bio-Medicus Cannula Kits, & Bio-Medicus Pediatric Cannula were modified to support longer-duration use in ECMO therapy to address COVID-19

Extracorporeal Membrane Oxygenation Cannula Market Segmentation

Grand View Research has segmented the global extracorporeal membrane oxygenation  cannula market based on type, patient type, application, end-use and region:

ECMO Cannula Type Outlook (Revenue, USD Million, 2018 - 2030)

• Veno-Arterial

• Veno-Venous

• Arterio-Venous

ECMO Cannula Patient Type Outlook (Revenue, USD Million, 2018 - 2030)

• Neonates

• Pediatric

• Adult

ECMO Cannula Application Outlook (Revenue, USD Million, 2018 - 2030)

• Respiratory

• Cardiac

• ECPR

ECMO Cannula End-use Outlook (Revenue, USD Million 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers

• Others

ECMO Cannula Regional Outlook (Revenue, USD Million 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Extracorporeal Membrane Oxygenation (ECMO) Cannula Market

• Medtronic

• LivaNova PLC

• Edwards Lifesciences Corporation

• Getinge

• Andocor

• Changzhou KangXin Medical Instruments Co., Ltd

• Free Life Medical GmbH

• Fresenius Medical Care AG

• Abbott